The Emerging Roles of STING in Bacterial Infections

Trends in Microbiology

Volumn 25, Issue 11, 2017, Pages 906-918

  Marinho, Fabio V ^a,b   Benmerzoug, Sulayman ^a,b   Oliveira, Sergio C ^b   Ryffel, Bernhard ^a,c   Quesniaux, V F J ^a,c  

^a CNRS   (France)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c UNIVERSITÉ D'ORLÉANS   (France)

Author keywords

bacteria; DNA and nucleotide sensing; infections; Stimulator of Interferon Genes; STING

Indexed keywords

ADAPTOR PROTEIN; CYCLIC DINUCLEOTIDE; DINUCLEOTIDE; PATHOGEN ASSOCIATED MOLECULAR PATTERN; STING PROTEIN; UNCLASSIFIED DRUG; MEMBRANE PROTEIN; MPYS PROTEIN, HUMAN;

ANTIBACTERIAL ACTIVITY; AUTOPHAGY; BACTERIAL INFECTION; BRUCELLA ABORTUS; CHLAMYDIA MURIDARUM; CHLAMYDIA TRACHOMATIS; CYTOSOL; ENDOPLASMIC RETICULUM; FRANCISELLA TULARENSIS; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; LISTERIA MONOCYTOGENES; MYCOBACTERIUM; MYCOBACTERIUM BOVIS; MYCOBACTERIUM LEPRAE; MYCOBACTERIUM TUBERCULOSIS; NEISSERIA GONORRHOEAE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SHIGELLA FLEXNERI; SIGNAL TRANSDUCTION; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; ANIMAL; BACTERIUM; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; INNATE IMMUNITY; MICROBIOLOGY; MOUSE; MYCOBACTERIOSIS;

ANIMALS; BACTERIA; BACTERIAL INFECTIONS; CYTOSOL; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; MEMBRANE PROTEINS; MICE; MYCOBACTERIUM; MYCOBACTERIUM INFECTIONS;

EID: 85020713077     PISSN: 0966842X     EISSN: 18784380     Source Type: Journal    
DOI: 10.1016/j.tim.2017.05.008     Document Type: Review

References (107)

1. Pandey, S., et al. Microbial sensing by Toll-like receptors and intracellular nucleic acid sensors. Cold Spring Harb. Perspect. Biol., 7, 2014, a016246.
2. Ishikawa, H., et al. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 461 (2009), 788–792.
3. Schoggins, J.W., et al. Corrigendum: Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity. Nature, 525, 2015, 144.
4. Ma, Z., et al. Modulation of the cGAS-STING DNA sensing pathway by gammaherpesviruses. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), E4306–E4315.
5. Schoggins, J.W., et al. Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity. Nature 505 (2014), 691–695.
6. Manzanillo, P.S., et al. Mycobacterium tuberculosis activates the DNA-dependent cytosolic surveillance pathway within macrophages. Cell Host Microbe 11 (2012), 469–480.
7. Barker, J.R., et al. STING-dependent recognition of cyclic di-AMP mediates type I interferon responses during Chlamydia trachomatis infection. mBio 4 (2013), e00018–00013.
8. Woodward, J.J., et al. c-di-AMP secreted by intracellular Listeria monocytogenes activates a host type I interferon response. Science 328 (2010), 1703–1705.
9. Gratz, N., et al. Type I interferon production induced by Streptococcus pyogenes-derived nucleic acids is required for host protection. PLoS Pathog., 7, 2011, e1001345.
10. Woo, S.R., et al. STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors. Immunity 41 (2014), 830–842.
11. Barber, G.N., STING-dependent cytosolic DNA sensing pathways. Trends Immunol. 35 (2014), 88–93.
12. Ma, Z., Damania, B., The cGAS-STING defense pathway and its counteraction by viruses. Cell Host Microbe 19 (2016), 150–158.
13. Lemos, H., et al. STING, nanoparticles, autoimmune disease and cancer: a novel paradigm for immunotherapy?. Expert Rev. Clin. Immunol. 11 (2015), 155–165.
14. Tamayo, R., et al. Roles of cyclic diguanylate in the regulation of bacterial pathogenesis. Annu. Rev. Microbiol. 61 (2007), 131–148.
15. Romling, U., Great times for small molecules: c-di-AMP, a second messenger candidate in Bacteria and Archaea. Sci. Signal., 1, 2008, pe39.
16. Parvatiyar, K., et al. The helicase DDX41 recognizes the bacterial secondary messengers cyclic di-GMP and cyclic di-AMP to activate a type I interferon immune response. Nat. Immunol. 13 (2012), 1155–1161.
17. McWhirter, S.M., et al. A host type I interferon response is induced by cytosolic sensing of the bacterial second messenger cyclic-di-GMP. J. Exp. Med. 206 (2009), 1899–1911.
18. Wu, J., et al. Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science 339 (2013), 826–830.
19. Spelbrink, J.N., Functional organization of mammalian mitochondrial DNA in nucleoids: history, recent developments, and future challenges. IUBMB Life 62 (2010), 19–32.
20. West, A.P., et al. Mitochondrial DNA stress primes the antiviral innate immune response. Nature 520 (2015), 553–557.
21. Carroll, E.C., et al. The vaccine adjuvant chitosan promotes cellular immunity via DNA sensor cGAS-STING-dependent induction of type I interferons. Immunity 44 (2016), 597–608.
22. Luo, W.W., et al. iRhom2 is essential for innate immunity to DNA viruses by mediating trafficking and stability of the adaptor STING. Nat. Immunol. 17 (2016), 1057–1066.
23. Saitoh, T., et al. Atg9a controls dsDNA-driven dynamic translocation of STING and the innate immune response. Proc. Natl. Acad. Sci. U. S. A. 106 (2009), 20842–20846.
24. Tanaka, Y., Chen, Z.J., STING specifies IRF3 phosphorylation by TBK1 in the cytosolic DNA signaling pathway. Sci. Signal., 5, 2012, ra20.
25. Zhong, B., et al. The ubiquitin ligase RNF5 regulates antiviral responses by mediating degradation of the adaptor protein MITA. Immunity 30 (2009), 397–407.
26. Konno, H., et al. Cyclic dinucleotides trigger ULK1 (ATG1) phosphorylation of STING to prevent sustained innate immune signaling. Cell 155 (2013), 688–698.
27. Wang, Y., et al. TRIM30alpha is a negative-feedback regulator of the intracellular DNA and DNA virus-triggered response by targeting STING. PLoS Pathog., 11, 2015, e1005012.
28. Barber, G.N., STING: infection, inflammation and cancer. Nat. Rev. Immunol. 15 (2015), 760–770.
29. Dobbs, N., et al. STING activation by translocation from the ER is associated with infection and autoinflammatory disease. Cell Host Microbe 18 (2015), 157–168.
30. Hammaker, D., et al. Synoviocyte innate immune responses: TANK-binding kinase-1 as a potential therapeutic target in rheumatoid arthritis. Rheumatology 51 (2012), 610–618 (Oxford).
31. Pomerantz, J.L., Baltimore, D., NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase. EMBO J. 18 (1999), 6694–6704.
32. Panday, A., et al. Transcription factor NF-kappaB: an update on intervention strategies. Arch. Immunol. Ther. Exp. 64 (2016), 463–483 (Warsz).
33. Chen, H., et al. Activation of STAT6 by STING is critical for antiviral innate immunity. Cell 147 (2011), 436–446.
34. Desai, M., et al. The role of autophagy in microbial infection and immunity. Immunotargets Ther. 4 (2015), 13–26.
35. Svenning, S., Johansen, T., Selective autophagy. Essays Biochem. 55 (2013), 79–92.
36. Watson, R.O., et al. Extracellular M. tuberculosis DNA targets bacteria for autophagy by activating the host DNA-sensing pathway. Cell 150 (2012), 803–815.
37. Watson, R.O., et al. The cytosolic sensor cGAS detects Mycobacterium tuberculosis DNA to induce type I interferons and activate autophagy. Cell Host Microbe 17 (2015), 811–819.
38. Jonsson, K.L., et al. IFI16 is required for DNA sensing in human macrophages by promoting production and function of cGAMP. Nat. Commun., 8, 2017, 14391.
39. Unterholzner, L., et al. IFI16 is an innate immune sensor for intracellular DNA. Nat. Immunol. 11 (2010), 997–1004.
40. Jakobsen, M.R., et al. IFI16 senses DNA forms of the lentiviral replication cycle and controls HIV-1 replication. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), E4571–E4580.
41. Dutta, D., et al. BRCA1 Regulates IFI16 mediated nuclear innate sensing of herpes viral DNA and subsequent induction of the innate inflammasome and interferon-beta responses. PLoS Pathog., 11, 2015, e1005030.
42. Omura, H., et al. Structural and functional analysis of DDX41: a bispecific immune receptor for DNA and cyclic dinucleotide. Sci. Rep., 6, 2016, 34756.
43. Lee, K.G., et al. Bruton's tyrosine kinase phosphorylates DDX41 and activates its binding of dsDNA and STING to initiate type 1 interferon response. Cell Rep. 10 (2015), 1055–1065.
44. Poli, C., et al. IL-26 Confers proinflammatory properties to extracellular DNA. J. Immunol. 198 (2017), 3650–3661.
45. Sun, L., et al. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 339 (2013), 786–791.
46. Civril, F., et al. Structural mechanism of cytosolic DNA sensing by cGAS. Nature 498 (2013), 332–337.
47. Ablasser, A., et al. cGAS produces a 2′-5′-linked cyclic dinucleotide second messenger that activates STING. Nature 498 (2013), 380–384.
48. Diner, E.J., et al. The innate immune DNA sensor cGAS produces a noncanonical cyclic dinucleotide that activates human STING. Cell Rep. 3 (2013), 1355–1361.
49. Orzalli, M.H., et al. cGAS-mediated stabilization of IFI16 promotes innate signaling during herpes simplex virus infection. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), E1773–E1781.
50. Holm, C.K., et al. Influenza A virus targets a cGAS-independent STING pathway that controls enveloped RNA viruses. Nat. Commun., 7, 2016, 10680.
51. + T cells. Cell Rep. 17 (2016), 413–424.
52. Mankan, A.K., et al. Cytosolic RNA:DNA hybrids activate the cGAS-STING axis. EMBO J. 33 (2014), 2937–2946.
53. Bridgeman, A., et al. Viruses transfer the antiviral second messenger cGAMP between cells. Science 349 (2015), 1228–1232.
54. Gentili, M., et al. Transmission of innate immune signaling by packaging of cGAMP in viral particles. Science 349 (2015), 1232–1236.
55. Liu, T.T., et al. LSm14A Plays a critical role in antiviral immune responses by regulating MITA level in a cell-specific manner. J. Immunol. 196 (2016), 5101–5111.
56. Zhang, L., et al. NLRC3, a member of the NLR family of proteins, is a negative regulator of innate immune signaling induced by the DNA sensor STING. Immunity 40 (2014), 329–341.
57. Zhou, Q., et al. The ER-associated protein ZDHHC1 is a positive regulator of DNA virus-triggered, MITA/STING-dependent innate immune signaling. Cell Host Microbe 16 (2014), 450–461.
58. Man, S.M., et al. DNA-sensing inflammasomes: regulation of bacterial host defense and the gut microbiota. Pathog. Dis., 74, 2016, ftw028.
59. Burckstummer, T., et al. An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome. Nat. Immunol. 10 (2009), 266–272.
60. Hornung, V., et al. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 458 (2009), 514–518.
61. Gray, E.E., et al. The AIM2-like receptors are dispensable for the interferon response to intracellular DNA. Immunity 45 (2016), 255–266.
62. Corrales, L., et al. Antagonism of the STING pathway via activation of the AIM2 inflammasome by intracellular DNA. J. Immunol. 196 (2016), 3191–3198.
63. Liu, C., et al. AIM2 inhibits autophagy and IFN-beta production during M. bovis infection. Oncotarget 7 (2016), 46972–46987.
64. Jones, J.W., et al. Absent in melanoma 2 is required for innate immune recognition of Francisella tularensis. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 9771–9776.
65. Meunier, E., et al. Guanylate-binding proteins promote activation of the AIM2 inflammasome during infection with Francisella novicida. Nat. Immunol. 16 (2015), 476–484.
66. de Vasconcelos, N.M., et al. Inflammasomes as polyvalent cell death platforms. Cell. Mol. Life Sci. 73 (2016), 2335–2347.
67. Oppenheimer-Shaanan, Y., et al. c-di-AMP reports DNA integrity during sporulation in Bacillus subtilis. EMBO Rep. 12 (2011), 594–601.
68. Corrigan, R.M., et al. c-di-AMP is a new second messenger in Staphylococcus aureus with a role in controlling cell size and envelope stress. PLoS Pathog., 7, 2011, e1002217.
69. Davies, B.W., et al. Coordinated regulation of accessory genetic elements produces cyclic di-nucleotides for V. cholerae virulence. Cell 149 (2012), 358–370.
70. Bisno, A.L., et al. Molecular basis of group A streptococcal virulence. Lancet Infect. Dis. 3 (2003), 191–200.
71. LaPenta, D., et al. Group A streptococci efficiently invade human respiratory epithelial cells. Proc. Natl. Acad. Sci. U. S. A. 91 (1994), 12115–12119.
72. Gratz, N., et al. Group A Streptococcus activates type I interferon production and MyD88-dependent signaling without involvement of TLR2, TLR4, and TLR9. J. Biol. Chem. 283 (2008), 19879–19887.
73. Kamegaya, T., et al. Identification of a Streptococcus pyogenes SF370 gene involved in production of c-di-AMP. Nagoya J. Med. Sci. 73 (2011), 49–57.
74. Mancuso, G., et al. Type I IFN signaling is crucial for host resistance against different species of pathogenic bacteria. J. Immunol. 178 (2007), 3126–3133.
75. Charrel-Dennis, M., et al. TLR-independent type I interferon induction in response to an extracellular bacterial pathogen via intracellular recognition of its DNA. Cell Host Microbe 4 (2008), 543–554.
76. Andrade, W.A., et al. Group B Streptococcus degrades cyclic-di-AMP to modulate STING-dependent type I interferon production. Cell Host Microbe 20 (2016), 49–59.
77. Parker, D., et al. Streptococcus pneumoniae DNA initiates type I interferon signaling in the respiratory tract. mBio 2 (2011), e00016–00011.
78. Koppe, U., et al. Streptococcus pneumoniae stimulates a STING- and IFN regulatory factor 3-dependent type I IFN production in macrophages, which regulates RANTES production in macrophages, cocultured alveolar epithelial cells, and mouse lungs. J. Immunol. 188 (2012), 811–817.
79. Mitzel, D.N., et al. Age-enhanced endoplasmic reticulum stress contributes to increased Atg9A inhibition of STING-mediated IFN-beta production during Streptococcus pneumoniae infection. J. Immunol. 192 (2014), 4273–4283.
80. Chateau, A., Seifert, H.S., Neisseria gonorrhoeae survives within and modulates apoptosis and inflammatory cytokine production of human macrophages. Cell. Microbiol. 18 (2016), 546–560.
81. Andrade, W.A., et al. Type I interferon induction by Neisseria gonorrhoeae: dual requirement of cyclic GMP-AMP synthase and Toll-like receptor 4. Cell Rep. 15 (2016), 2438–2448.
82. Prantner, D., et al. Stimulator of IFN gene is critical for induction of IFN-beta during Chlamydia muridarum infection. J. Immunol. 184 (2010), 2551–2560.
83. Zhang, Y., et al. The DNA sensor, cyclic GMP-AMP synthase, is essential for induction of IFN-beta during Chlamydia trachomatis infection. J. Immunol. 193 (2014), 2394–2404.
84. Wilson, D.P., et al. Type III secretion, contact-dependent model for the intracellular development of chlamydia. Bull. Math. Biol. 68 (2006), 161–178.
85. Schwartz, K.T., et al. Hyperinduction of host beta interferon by a Listeria monocytogenes strain naturally overexpressing the multidrug efflux pump MdrT. Infect. Immun. 80 (2012), 1537–1545.
86. Hansen, K., et al. Listeria monocytogenes induces IFNbeta expression through an IFI16-, cGAS- and STING-dependent pathway. EMBO J. 33 (2014), 1654–1666.
87. Sauer, J.D., et al. The N-ethyl-N-nitrosourea-induced Goldenticket mouse mutant reveals an essential function of Sting in the in vivo interferon response to Listeria monocytogenes and cyclic dinucleotides. Infect. Immun. 79 (2011), 688–694.
88. de Almeida, L.A., et al. MyD88 and STING signaling pathways are required for IRF3-mediated IFN-beta induction in response to Brucella abortus infection. PLoS One, 6, 2011, e23135.
89. Khan, M., et al. The bacterial second messenger cyclic-di-GMP regulates Brucella pathogenesis and leads to altered host immune response. Infect. Immun. 84 (2016), 3458–3470.
90. Burnaevskiy, N., et al. Proteolytic elimination of N-myristoyl modifications by the Shigella virulence factor IpaJ. Nature 496 (2013), 106–109.
91. Dong, N., et al. Structurally distinct bacterial TBC-like GAPs link Arf GTPase to Rab1 inactivation to counteract host defenses. Cell 150 (2012), 1029–1041.
92. Zheng, Z., et al. Bacterial E3 ubiquitin ligase IpaH4.5 of Shigella flexneri targets TBK1 to dampen the host antibacterial response. J. Immunol. 196 (2016), 1199–1208.
93. Birmingham, C.L., et al. Autophagy controls Salmonella infection in response to damage to the Salmonella-containing vacuole. J. Biol. Chem. 281 (2006), 11374–11383.
94. Owen, K.A., et al. Salmonella suppresses the TRIF-dependent type I interferon response in macrophages. mBio 7 (2016), e02051–02015.
95. Perkins, D.J., et al. Salmonella Typhimurium co-opts the host type I IFN system to restrict macrophage innate immune transcriptional responses selectively. J. Immunol. 195 (2015), 2461–2471.
96. Deriu, E., et al. Influenza virus affects intestinal microbiota and secondary Salmonella infection in the gut through type I interferons. PLoS Pathog., 12, 2016, e1005572.
97. Zumla, A., et al. The WHO 2014 global tuberculosis report–further to go. Lancet Glob. Health 3 (2015), e10–e12.
98. Abdallah, A.M., et al. Type VII secretion – mycobacteria show the way. Nat. Rev. Microbiol. 5 (2007), 883–891.
99. Collins, A.C., et al. Cyclic GMP-AMP synthase is an innate immune DNA sensor for Mycobacterium tuberculosis. Cell Host Microbe 17 (2015), 820–828.
100. Dey, B., et al. A bacterial cyclic dinucleotide activates the cytosolic surveillance pathway and mediates innate resistance to tuberculosis. Nat. Med. 21 (2015), 401–406.
101. Wassermann, R., et al. Mycobacterium tuberculosis differentially activates cGAS- and inflammasome-dependent intracellular immune responses through ESX-1. Cell Host Microbe 17 (2015), 799–810.
102. Manzanillo, P.S., et al. The ubiquitin ligase parkin mediates resistance to intracellular pathogens. Nature 501 (2013), 512–516.
103. Pilli, M., et al. TBK-1 promotes autophagy-mediated antimicrobial defense by controlling autophagosome maturation. Immunity 37 (2012), 223–234.
104. Gutierrez, M.G., et al. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell 119 (2004), 753–766.
105. Choi, U.Y., et al. Oligoadenylate synthase-like (OASL) proteins: dual functions and associations with diseases. Exp. Mol. Med., 47, 2015, e144.
106. de Toledo-Pinto, T.G., et al. STING-dependent 2′-5′ oligoadenylate synthetase-like production is required for intracellular Mycobacterium leprae survival. J. Infect. Dis. 214 (2016), 311–320.
107. Wiens, K.E., Ernst, J.D., The mechanism for type I interferon induction by Mycobacterium tuberculosis is bacterial strain-dependent. PLoS Pathog., 12, 2016, e1005809.